These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 7988621

  • 21. Viscum album L. extracts reduce sister chromatid exchanges in cultured peripheral blood mononuclear cells.
    Büssing A, Azhari T, Ostendorp H, Lehnert A, Schweizer K.
    Eur J Cancer; 1994; 30A(12):1836-41. PubMed ID: 7880615
    [Abstract] [Full Text] [Related]

  • 22. Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo.
    Hajto T, Hostanska K, Weber K, Zinke H, Fischer J, Mengs U, Lentzen H, Saller R.
    Nat Immun; 1998; 16(1):34-46. PubMed ID: 9789123
    [Abstract] [Full Text] [Related]

  • 23. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts.
    Stein GM, Stettin A, Schultze J, Berg PA.
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S57-9. PubMed ID: 9179370
    [Abstract] [Full Text] [Related]

  • 24. Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro.
    Kelter G, Fiebig HH.
    Arzneimittelforschung; 2006 Jun; 56(6A):435-40. PubMed ID: 16927523
    [Abstract] [Full Text] [Related]

  • 25. Isolation and characterization of mistletoe extracts (Viscum album L.). I. Affinity chromatography of mistletoe extracts on immobilized plasma proteins.
    Franz H, Haustein B, Luther P, Kuropka U, Kindt A.
    Acta Biol Med Ger; 1977 Jun; 36(1):113-7. PubMed ID: 878740
    [Abstract] [Full Text] [Related]

  • 26. Effects of Viscum album L. on cyclophosphamide-treated peripheral blood mononuclear cells in vitro: sister chromatid exchanges and activation/proliferation marker expression.
    Büssing A, Regnery A, Schweizer K.
    Cancer Lett; 1995 Aug 01; 94(2):199-205. PubMed ID: 7634248
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Immunomodulatory effects of iscador: a Viscum album preparation.
    Hajto T.
    Oncology; 1986 Aug 01; 43 Suppl 1():51-65. PubMed ID: 2433654
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of Korean mistletoe lectin (Viscum album coloratum) on proliferation and cytokine expression in human peripheral blood mononuclear cells and T-lymphocytes.
    Lyu SY, Park WB.
    Arch Pharm Res; 2007 Oct 01; 30(10):1252-64. PubMed ID: 18038904
    [Abstract] [Full Text] [Related]

  • 31. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
    Jung ML, Baudino S, Ribéreau-Gayon G, Beck JP.
    Cancer Lett; 1990 May 30; 51(2):103-8. PubMed ID: 2344587
    [Abstract] [Full Text] [Related]

  • 32. Immunomodulatory effects of Viscum album agglutinin-I on natural immunity.
    Hajto T, Hostanska K, Fischer J, Saller R.
    Anticancer Drugs; 1997 Apr 30; 8 Suppl 1():S43-6. PubMed ID: 9179367
    [Abstract] [Full Text] [Related]

  • 33. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
    Felenda JE, Turek C, Stintzing FC.
    J Ethnopharmacol; 2019 May 23; 236():100-107. PubMed ID: 30840914
    [Abstract] [Full Text] [Related]

  • 34. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
    Ribéreau-Gayon G, Jung ML, Di Scala D, Beck JP.
    Oncology; 1986 May 23; 43 Suppl 1():35-41. PubMed ID: 3808575
    [Abstract] [Full Text] [Related]

  • 35. [Mistletoe therapy from the pharmacologic perspective].
    Hajto T, Hostanska K, Saller R.
    Forsch Komplementarmed; 1999 Aug 23; 6(4):186-94. PubMed ID: 10529578
    [Abstract] [Full Text] [Related]

  • 36. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
    Ribéreau-Gayon G, Jung ML, Frantz M, Anton R.
    Anticancer Drugs; 1997 Apr 23; 8 Suppl 1():S3-8. PubMed ID: 9179359
    [Abstract] [Full Text] [Related]

  • 37. Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy.
    Stein G, Henn W, von Laue H, Berg P.
    Eur J Med Res; 1998 Apr 08; 3(4):194-202. PubMed ID: 9533928
    [Abstract] [Full Text] [Related]

  • 38. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
    Grossarth-Maticek R, Kiene H, Baumgartner SM, Ziegler R.
    Altern Ther Health Med; 2001 Apr 08; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
    [Abstract] [Full Text] [Related]

  • 39. Effects of a lectin- and a viscotoxin-rich mistletoe preparation on clinical and hematologic parameters: a placebo-controlled evaluation in healthy subjects.
    Huber R, Klein R, Berg PA, Lüdtke R, Werner M.
    J Altern Complement Med; 2002 Dec 08; 8(6):857-66. PubMed ID: 12614536
    [Abstract] [Full Text] [Related]

  • 40. In vitro investigation into the potential of a mistletoe extract to alleviate adverse effects of cyclophosphamide.
    Burkhart J, Wälchli C, Heusser P, Weissenstein U, Baumgartner S, Andres AC.
    Altern Ther Health Med; 2010 Dec 08; 16(3):40-8. PubMed ID: 20486623
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.